Total Payments
$431.40
2022 Payments
$34.80
Companies
15
Transactions
23
Medicare Patients
1,300
Medicare Billing
$165,402
Payment Breakdown by Category
Food & Beverage$431.40 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $431.40 | 23 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $74.27 | 2 | $0 (2017) |
| Radius Health, Inc. | $57.60 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $43.37 | 2 | $0 (2022) |
| Takeda Pharmaceuticals America, Inc. | $42.97 | 3 | $0 (2017) |
| Allergan Inc. | $37.45 | 2 | $0 (2017) |
| PFIZER INC. | $35.46 | 3 | $0 (2017) |
| SANOFI-AVENTIS U.S. LLC | $33.96 | 2 | $0 (2017) |
| Valeant Pharmaceuticals North America LLC | $17.77 | 1 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $15.71 | 1 | $0 (2017) |
| Daiichi Sankyo Inc. | $15.53 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $34.80 | 2 | AstraZeneca Pharmaceuticals LP ($22.76) |
| 2017 | $396.60 | 21 | Lilly USA, LLC ($74.27) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/21/2022 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/17/2022 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $12.04 | General |
| Category: COVID-19 | ||||||
| 11/06/2017 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $57.60 | General |
| Category: Endocrinology | ||||||
| 05/11/2017 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $61.27 | General |
| 02/24/2017 | PFIZER INC. | CHANTIX (Drug), VIAGRA, ELIQUIS | Food and Beverage | In-kind items and services | $10.39 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 02/21/2017 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: DIABETES | ||||||
| 02/21/2017 | Valeant Pharmaceuticals North America LLC | XIFAXANIBSD (Drug), UCERIS TABLETS, RELISTOR ORAL | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/16/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $11.32 | General |
| Category: Diabetes | ||||||
| 02/15/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: RESPIRATORY | ||||||
| 02/09/2017 | PFIZER INC. | EMBEDA (Drug) | Food and Beverage | In-kind items and services | $11.29 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 02/08/2017 | Allergan Inc. | VIBERZI (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/07/2017 | Daiichi Sankyo Inc. | Movantik (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Opioid Induced Constipation | ||||||
| 02/06/2017 | Takeda Pharmaceuticals America, Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: Central Nervous System (CNS) | ||||||
| 02/06/2017 | Takeda Pharmaceuticals America, Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $0.27 | General |
| Category: Central Nervous System (CNS) | ||||||
| 02/02/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/31/2017 | GlaxoSmithKline, LLC. | ADVAIR (Drug), FLOVENT | Food and Beverage | In-kind items and services | $11.69 | General |
| Category: RESPIRATORY | ||||||
| 01/30/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: DIABETES | ||||||
| 01/25/2017 | Purdue Pharma L.P. | — | Food and Beverage | Cash or cash equivalent | $11.72 | General |
| 01/23/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, ZOSTAVAX | Food and Beverage | In-kind items and services | $10.54 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/19/2017 | PFIZER INC. | TOVIAZ (Drug), LYRICA, VIAGRA | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: GENITOURINARY (UROLOGY) | ||||||
| 01/12/2017 | Takeda Pharmaceuticals America, Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: Central Nervous System (CNS) | ||||||
| 01/11/2017 | Lilly USA, LLC | FORTEO (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: Bone Muscle Joint | ||||||
| 01/09/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 423 | 659 | $365,449 | $60,163 |
| 2022 | 8 | 506 | 854 | $179,080 | $58,198 |
| 2021 | 7 | 371 | 520 | $141,065 | $47,041 |
Total Patients
1,300
Total Services
2,033
Medicare Billing
$165,402
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 140 | 311 | $202,345 | $28,970 | 14.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 128 | 132 | $82,001 | $11,931 | 14.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 62 | 122 | $32,260 | $7,385 | 22.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 55 | 55 | $31,755 | $7,058 | 22.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 25 | 25 | $7,750 | $2,448 | 31.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 13 | 14 | $9,338 | $2,370 | 25.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 177 | 439 | $72,435 | $23,968 | 33.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 72 | 149 | $35,164 | $11,430 | 32.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 133 | 141 | $34,404 | $10,948 | 31.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 49 | 50 | $15,500 | $5,187 | 33.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 28 | 28 | $12,852 | $4,236 | 33.0% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 16 | 16 | $4,928 | $1,521 | 30.9% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 12 | 12 | $1,992 | $598.40 | 30.0% |
| 94618 | Test for exercise-induced lung stress | Facility | 2022 | 19 | 19 | $1,805 | $309.91 | 17.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 115 | 120 | $37,200 | $12,613 | 33.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 81 | 81 | $37,179 | $12,309 | 33.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 68 | 192 | $31,680 | $10,615 | 33.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 26 | 44 | $10,384 | $3,471 | 33.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 44 | 45 | $10,980 | $3,439 | 31.3% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 16 | 17 | $7,174 | $2,401 | 33.5% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2021 | 21 | 21 | $6,468 | $2,193 | 33.9% |
About Amira Elmagbari, M.D, MSC
Amira Elmagbari, M.D, MSC is a Internal Medicine healthcare provider based in Parkersburg, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/30/2012. The National Provider Identifier (NPI) number assigned to this provider is 1427312875.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amira Elmagbari, M.D, MSC has received a total of $431.40 in payments from pharmaceutical and medical device companies, with $34.80 received in 2022. These payments were reported across 23 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($431.40).
As a Medicare-enrolled provider, Elmagbari has provided services to 1,300 Medicare beneficiaries, totaling 2,033 services with total Medicare billing of $165,402. Data is available for 3 years (2021–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Parkersburg, WV
- Active Since 06/30/2012
- Last Updated 04/20/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1427312875
Products in Payments
- Tymlos (Biological) $57.60
- Trintellix (Drug) $42.97
- BRILINTA (Drug) $22.76
- NAMZARIC (Drug) $21.48
- TOUJEO (Drug) $21.12
- FARXIGA (Drug) $20.61
- XIFAXANIBSD (Drug) $17.77
- VIBERZI (Drug) $15.97
- SPIRIVA (Drug) $15.71
- Movantik (Drug) $15.53
- TOVIAZ (Drug) $13.78
- FORTEO (Drug) $13.00
- SOLIQUA (Drug) $12.84
- Veklury (Drug) $12.04
- ADVAIR (Drug) $11.69
- Victoza (Drug) $11.32
- EMBEDA (Drug) $11.29
- JANUVIA (Drug) $10.54
- CHANTIX (Drug) $10.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Parkersburg
Jennifer Leavitt, D.o, D.O
Internal Medicine — Payments: $9,943
Internal Medicine $9,943
Orton Armstrong, M.d, M.D
Internal Medicine — Payments: $9,663
Internal Medicine $9,663
William Tomlinson, Md, MD
Internal Medicine — Payments: $8,023
Internal Medicine $8,023
Bairava Kuppuswamy, M.d, M.D
Internal Medicine — Payments: $6,502
Internal Medicine $6,502
Michael Cheshire, D.o, D.O
Internal Medicine — Payments: $5,388
Internal Medicine $5,388
Abiy Kelil, M.d, M.D
Internal Medicine — Payments: $3,922
Internal Medicine $3,922